These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24304170)

  • 41. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
    Waldmeier F; Glaenzel U; Wirz B; Oberer L; Schmid D; Seiberling M; Valencia J; Riviere GJ; End P; Vaidyanathan S
    Drug Metab Dispos; 2007 Aug; 35(8):1418-28. PubMed ID: 17510248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism and excretion of ropivacaine in humans.
    Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.
    Xie H; Zeng L; Zeng S; Lu X; Zhang G; Zhao X; Cheng N; Tu Z; Li Z; Xu H; Yang L; Zhang X; Huang M; Zhao J; Hu W
    Eur J Med Chem; 2012 Jun; 52():205-12. PubMed ID: 22475866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans.
    Karanam B; Madeira M; Bradley S; Wenning L; Desai R; Soli E; Schenk D; Jones A; Dean B; Doss G; Garrett G; Crumley T; Nirula A; Lai E
    Drug Metab Dispos; 2007 Jul; 35(7):1196-202. PubMed ID: 17431030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration.
    Woolley JL; Deangelis DV; Grace ME; Liao SH; Crouch RC; Sigel CW
    Drug Metab Dispos; 1991; 19(6):1139-46. PubMed ID: 1687022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption, metabolism, and excretion of [14C]viramidine in humans.
    Lin CC; Xu C; Zhu N; Yeh LT
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2368-73. PubMed ID: 16801414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption, metabolism and excretion of [
    Xu S; Tatosian D; Mcintosh I; Caceres M; Matthews C; Samuel K; Selverian D; Kumar S; Kauh E
    Xenobiotica; 2018 Jun; 48(6):584-591. PubMed ID: 28665228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects.
    Johnson TR; Tan W; Goulet L; Smith EB; Yamazaki S; Walker GS; O'Gorman MT; Bedarida G; Zou HY; Christensen JG; Nguyen LN; Shen Z; Dalvie D; Bello A; Smith BJ
    Xenobiotica; 2015 Jan; 45(1):45-59. PubMed ID: 25034009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and excretion of a novel p38 MAP kinase inhibitor pamapimod in healthy male subjects.
    Zhang X; Fettner S; Winter E; Masjedizadeh M; Hisoire G
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):345-52. PubMed ID: 21612741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
    Huskey SE; Zhu CQ; Fredenhagen A; Kühnöl J; Luneau A; Jian Z; Yang Z; Miao Z; Yang F; Jain JP; Sunkara G; Mangold JB; Stein DS
    Drug Metab Dispos; 2016 May; 44(5):672-82. PubMed ID: 26921387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolism and disposition of imatinib mesylate in healthy volunteers.
    Gschwind HP; Pfaar U; Waldmeier F; Zollinger M; Sayer C; Zbinden P; Hayes M; Pokorny R; Seiberling M; Ben-Am M; Peng B; Gross G
    Drug Metab Dispos; 2005 Oct; 33(10):1503-12. PubMed ID: 16006570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.